focus
Previous article:
Supreme Court strikes down use of affirmative action
Next article: Clinical trials giant ICON acquires HumanFirst
Next article: Clinical trials giant ICON acquires HumanFirst
explore
knowledge
-
FDA's Woodcock to retire early next year
2025-09-29 00:19 -
Flu vaccine offering decent levels of protection this winter, new data show
2025-09-29 00:02 -
ALS groups 'won't be played again' by the FDA, drug sponsors
2025-09-28 23:55 -
In key trial, Verve's treatment lowers cholesterol levels in patients
2025-09-28 23:48 -
How to fix the rural physician shortage in the U.S.
2025-09-28 23:35 -
ALS groups 'won't be played again' by the FDA, drug sponsors
2025-09-28 22:26